Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Finan

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Industrial Microbiology & Biotechnology|March 1, 2012
Partial deletion of rng (RNase G)-enhanced homoethanol fermentation of xylose by the non-transgenic Escherichia coli RM10Ryan Manow, Jinhua Wang, Yongze Wang, et al.
ESC Heart Failure|March 12, 2025
Atrial fibrillation development in the heart failure population from nationwide British linked electronic health recordsHiroyuki Yoshimura, Nikhil Paliwal, Arturo Gonzalez-Izquierdo, et al.
Open Biology|July 16, 2024
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.
The Pharmacogenomics Journal|July 30, 2014
Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian populationFasil Tekola-Ayele, Adebowale Adeyemo, Abraham Aseffa, et al.
Nature Communications|December 21, 2021
Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genomeCatherine S Storm, Demis A Kia, Mona M Almramhi, et al.
European Heart Journal. Digital Health|July 24, 2025
Clustering of electronic health records in atrial fibrillation patients and impact on prognosis and patient trajectories: a UK linked-dataset studyZengqi Zhang, Hiroyuki Yoshimura, Dionisio Acosta-Mena, et al.
JAMA Cardiology|August 3, 2022
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization StudyArjen J Cupido, Laurens F Reeskamp, Aroon D Hingorani, et al.
Genome Medicine|October 21, 2024
Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillationMarion van Vugt, Chris Finan, Sandesh Chopade, et al.
Human Molecular Genetics|March 29, 2020
Polygenic risk scores for coronary artery disease and subsequent event risk amongst established casesLaurence J Howe, Frank Dudbridge, Amand F Schmidt, et al.
Plos One|July 5, 2012
Prediction of HLA class II alleles using SNPs in an African populationFasil Tekola Ayele, Fasil Tekola Ayele, Elena Hailu, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Industrial Microbiology & Biotechnology|March 1, 2012
Partial deletion of rng (RNase G)-enhanced homoethanol fermentation of xylose by the non-transgenic Escherichia coli RM10Ryan Manow, Jinhua Wang, Yongze Wang, et al.
ESC Heart Failure|March 12, 2025
Atrial fibrillation development in the heart failure population from nationwide British linked electronic health recordsHiroyuki Yoshimura, Nikhil Paliwal, Arturo Gonzalez-Izquierdo, et al.
Open Biology|July 16, 2024
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.
The Pharmacogenomics Journal|July 30, 2014
Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian populationFasil Tekola-Ayele, Adebowale Adeyemo, Abraham Aseffa, et al.
Nature Communications|December 21, 2021
Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genomeCatherine S Storm, Demis A Kia, Mona M Almramhi, et al.
European Heart Journal. Digital Health|July 24, 2025
Clustering of electronic health records in atrial fibrillation patients and impact on prognosis and patient trajectories: a UK linked-dataset studyZengqi Zhang, Hiroyuki Yoshimura, Dionisio Acosta-Mena, et al.
JAMA Cardiology|August 3, 2022
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization StudyArjen J Cupido, Laurens F Reeskamp, Aroon D Hingorani, et al.
Genome Medicine|October 21, 2024
Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillationMarion van Vugt, Chris Finan, Sandesh Chopade, et al.
Human Molecular Genetics|March 29, 2020
Polygenic risk scores for coronary artery disease and subsequent event risk amongst established casesLaurence J Howe, Frank Dudbridge, Amand F Schmidt, et al.
Plos One|July 5, 2012
Prediction of HLA class II alleles using SNPs in an African populationFasil Tekola Ayele, Fasil Tekola Ayele, Elena Hailu, et al.
Pageof 8